Abstract:
The invention provides compositions and methods useful for identifying, verifying or authenticating any type of sample, whether the sample, is biological or non-biological.
Abstract:
Compounds which may be used in the treatment and/or prevention of cancer have the formula (I): wherein R1 and R2 together with the ring to which they are bound represent a saturated or unsaturated carbocyclic or heterocyclic group
Abstract:
The present invention relates to the use of certain osmium containing complexes such as cytotoxic agents particularly for the treatment of cancer. There is also provided novel osmium containing complexes, as well as pharmaceutical formulations comprising such complexes.
Abstract:
Embodiments of the invention provide systems, assemblies and methods for packaging hearing devices to protect them during shipping and storage. Many embodiments provide packaging systems that allow metal-air battery powered hearing aids to be stored for several months or longer with a live battery and then ready for use upon opening of the packaging. One embodiment provides a packaging system for a hearing aid comprising a packaging container and a hearing aid disposed in the container. The container comprises an air-impermeable material and has a removal cap that forms an air-impermeable seal with the container. The hearing aid can be positioned on a compliant support coupled to the interior surface of the cap. The support and container protect the hearing aid from shock and vibration as well as reducing the application of force to sensitive components. The container can also include one or more structures for ESD protection.
Abstract:
A hinge mechanism pivotally connects first and second housings of an electronics device. The hinge includes a bracket, a floating shaft, a cam member, and a biasing system. The cam member is mounted on the floating shaft. The biasing system is disposed within the first housing, and includes one or more biasing members that allow the cam member and the floating shaft to move axially in a first direction. The one or more biasing members also bias the cam member and the floating shaft in a second, opposing direction. Biasing the floating shaft and the cam member in the second direction maintains the pivotable connection between the first and second housings, and generates the force necessary to yieldingly resist a user pivoting at least one of the first and second housings.
Abstract:
Embodiments of the invention provide seals for retaining hearing devices in the ear canal. An embodiment provides a seal for a hearing device comprising a curved shell having a wall and an opening at a shell apex portion. The shell wall defines a cavity for retention of a hearing device component with at least a portion of the shell comprising a resilient material having sound attenuating properties. The shell has a structure such that a force for removal of the seal from the canal is greater than a force for insertion of the seal into the canal. That structure can have an umbrella or cup shape. The structure can be configured to act as a mechanical toggle when acted upon by a laterally applied force to the shell. The structure can also be configured to exert a constant frictional force against the canal wall during insertion into the ear canal.
Abstract:
Methods for correcting systematic errors in the measured position of deposited features of a nucleic acid array on a substrate. Systematic errors are modeled by an algorithmic model based on measuring the positions (and possibly other properties) of a subset of the features, and a model is constructed for predicting deviations in feature position from an ideal grid. Deviations arising in the deposition process, the scanning process, or both may be corrected.
Abstract:
The invention provides compositions and methods useful for identifying, verifying or authenticating any type of sample, whether the sample, is biological or non-biological.
Abstract:
Compounds which may be used in the treatment and/or prevention of cancer have the formula (I) wherein: R1, R2, R3, R4, R5 and R6 independently represents H, alkyl, —CO2R′, aryl or akylaryl, which latter two groups are optionally substituted on the aromatic ring; R′ represent alkyl, aryl or alkaryl; X is halo, H2O, (R′)(R″)SO, R′CO2— or (R′)(R″)C═O, where R″ represents alkyl, aryl or alkaryl; Y is a counterion; m is 0 or 1; q is 1, 2 or 3; C′ is C1 to C12 alkylene, optionally substituted in or on the alkylene chain, bound to two A groups; p is 0 or 1 and r is 1 when p is 0 and r is 2 when p is 1; and A and B are: each independently N-donor nitrile ligands; or B is halo and A is an N-donor pyridine ligand, optionally substituted at one or more of the carbon atoms of the pyridine ring; or p is 0, A is NR7R8 and B is NR9R10, wherein R7, R8, R9 and R10 independently represent H or alkyl, and A and B are linked by an alkylene chain, optionally substituted in or on the alkylene chain, or p is 1, A is NR7 and B is NR9R10, wherein R7, R9 and R10 are as previously defined, and A and B are linked by an alkylene chain, optionally substituted.